Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer
Clinical trial NCT00004070 · COMPLETED
Trial details
- NCT number
- NCT00004070
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-07-01
- Primary completion
- 2000-11-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.